BridgeMD
New treatment option for Low Back Pain
Official title Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome
ClinicalTrials.gov ID: NCT07463729
What this study is testing
- What it's testing
- The aim of the study is to evaluate the effects of biofeedback-assisted stabilization training and conventional therapy on pain perception, balance, spinal mobility, functional performance, physical activity, stress level, and quality of life in patients with lumbosacral spine pain syndrome treated conservatively. The main research questions the study seeks to answer are as follows: Whether and to what extent the implemented therapeutic program improves balance, spinal mobility, functional performance, physical activity, quality of life, and reduces pain perception and stress levels in patients with lumbosacral spine pain syndrome?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 65
You may be able to join if
- Diagnosed chronic lumbosacral spine pain syndrome (score \>4 on the Keele STarT Back Screening Tool)
- Lumbosacral pain intensity \>3 on the Visual Analog Scale (VAS) persisting for at least the past 3 months
- Age between 30 and 65 years
- No concurrent participation in another rehabilitation program
- Provision of written informed consent to participate in the study
You likely can't join if
- Acute phase of lumbosacral spine pain syndrome
- Presence of neurological symptoms such as paresthesia, dysesthesia, impaired superficial sensation, impaired pain sensation, muscle strength below...
- Recent fractures of the spine or pelvis (less than 6 months since injury)
- Segmental instability confirmed by functional X-ray or magnetic resonance imaging (MRI)
- Spondylolisthesis greater than Grade I according to the Meyerding classification
- Coexisting neurological (e.g., Parkinson's disease, neuropathies), autoimmune (e.g., ankylosing spondylitis), orthopedic (lower limb disorders), or...
See the full eligibility criteria
- Diagnosed chronic lumbosacral spine pain syndrome (score \>4 on the Keele STarT Back Screening Tool)
- Lumbosacral pain intensity \>3 on the Visual Analog Scale (VAS) persisting for at least the past 3 months
- Age between 30 and 65 years
- No concurrent participation in another rehabilitation program
- Provision of written informed consent to participate in the study
- Acute phase of lumbosacral spine pain syndrome
- Presence of neurological symptoms such as paresthesia, dysesthesia, impaired superficial sensation, impaired pain sensation, muscle strength below grade 3 on the Lovett scale in the lower limbs, sphincter dysfunction...
- Recent fractures of the spine or pelvis (less than 6 months since injury)
- Segmental instability confirmed by functional X-ray or magnetic resonance imaging (MRI)
- Spondylolisthesis greater than Grade I according to the Meyerding classification
- Coexisting neurological (e.g., Parkinson's disease, neuropathies), autoimmune (e.g., ankylosing spondylitis), orthopedic (lower limb disorders), or oncological diseases
- Pregnancy
- Active use of analgesic or anti-inflammatory pharmacotherapy (e.g., steroids, NSAIDs)
- Concurrent participation in other rehabilitation programs or failure to complete the 8-week therapy program
- Completion of any structured rehabilitation program within the past 3 months
- Lack of informed consent to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Tarnów, Małopolska, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tarnów, Małopolska, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.